Adam Spice Sells 9,677 Shares of Rocket Lab (NASDAQ:RKLB) Stock

Key Points

• Rocket Lab CFO Adam Spice sold 9,677 shares for approximately $673,810 under a pre-arranged Rule 10b5-1 plan to cover tax obligations from vested equity awards. He retains 1,155,967 shares.
• Rocket Lab shares fell 1.1% to $66.18, while the company’s latest quarterly results missed earnings expectations despite revenue slightly exceeding forecasts. The company remains unprofitable, with a negative net margin and an elevated valuation.
• Analysts remain broadly bullish, with a consensus “Moderate Buy” rating and an average price target of $110.65, though potential delays to the Neutron rocket and insider selling remain key risks.

Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) CFO Adam Spice sold 9,677 shares of the company's stock in a transaction on Monday, August 24th. The shares were sold at an average price of $69.63, for a total transaction of $673,809.51. Following the completion of the transaction, the chief financial officer owned 1,155,967 shares of the company's stock, valued at $80,489,982.21. This trade represents a 0.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Rocket Lab Stock Down 1.1%

Rocket Lab stock traded down $0.73 during midday trading on Wednesday, hitting $66.18. 10,986,209 shares of the stock were exchanged, compared to its average volume of 18,443,292. Rocket Lab Corporation has a 1 year low of $37.57 and a 1 year high of $151.00. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98. The firm has a market cap of $39.60 billion, a P/E ratio of -245.10 and a beta of 2.60. The company has a 50 day moving average price of $79.45 and a two-hundred day moving average price of $85.15.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last posted its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The firm had revenue of $234.07 million during the quarter, compared to analysts' expectations of $231.62 million. On average, sell-side analysts predict that Rocket Lab Corporation will post -0.2 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Rocket Lab

Hedge funds have recently bought and sold shares of the company. AQR Capital Management LLC boosted its position in Rocket Lab by 114.0% during the first quarter. AQR Capital Management LLC now owns 174,308 shares of the rocket manufacturer's stock valued at $3,117,000 after acquiring an additional 92,849 shares during the last quarter. NewEdge Advisors LLC raised its position in shares of Rocket Lab by 1,812.1% in the 1st quarter. NewEdge Advisors LLC now owns 36,807 shares of the rocket manufacturer's stock worth $658,000 after acquiring an additional 34,882 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in shares of Rocket Lab by 53.8% in the 1st quarter. Jones Financial Companies Lllp now owns 15,745 shares of the rocket manufacturer's stock valued at $282,000 after purchasing an additional 5,507 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Rocket Lab by 13.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 773,548 shares of the rocket manufacturer's stock valued at $13,831,000 after purchasing an additional 90,758 shares in the last quarter. Finally, Focus Partners Wealth boosted its position in shares of Rocket Lab by 1.0% during the 1st quarter. Focus Partners Wealth now owns 67,584 shares of the rocket manufacturer's stock valued at $1,206,000 after purchasing an additional 681 shares in the last quarter. Institutional investors own 71.78% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Citigroup restated a "market outperform" rating on shares of Rocket Lab in a research note on Tuesday, July 28th. Stifel Nicolaus set a $132.00 price objective on Rocket Lab in a report on Thursday, June 4th. Weiss Ratings restated a "sell (d-)" rating on shares of Rocket Lab in a research report on Friday, July 17th. Morgan Stanley reaffirmed an "overweight" rating on shares of Rocket Lab in a research note on Wednesday, July 8th. Finally, Citizens Jmp reiterated a "market outperform" rating and set a $130.00 price target on shares of Rocket Lab in a research report on Tuesday, August 11th. Three analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Rocket Lab has an average rating of "Moderate Buy" and a consensus target price of $110.65.

Rocket Lab News Summary

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Defense contract expands Rocket Lab’s backlog. Viasat selected Rocket Lab to build spacecraft buses for the U.S. Space Force’s Protected Tactical SATCOM-Global program. The initial “Swarm 1” award is part of Viasat’s $218.8 million prime contract and reinforces Rocket Lab’s growing role in government space infrastructure. Why Rocket Lab Could Outpace Viasat as Defense Space Spending Accelerates
• Positive Sentiment: Optical communications could broaden revenue opportunities. Rocket Lab’s optical communications terminals are being tested aboard KSAT’s Hyperion satellite, extending the company beyond launch services and into high-bandwidth satellite communications infrastructure. What Does Rocket Lab Gain From Its Optical Communications Role?
• Neutral Sentiment: Analysts remain broadly optimistic, but valuation is demanding. Coverage highlights strong revenue growth, a sizable backlog and multiple price targets well above the current trading level. However, Rocket Lab remains unprofitable, with high-growth expectations already reflected in its valuation. Is It Worth Investing in Rocket Lab Based on Wall Street’s Bullish Views?
• Negative Sentiment: Neutron delays are the main overhang. Reports warn that Rocket Lab’s medium-lift Neutron rocket debut could slip into 2027. A delay would postpone a major expected growth catalyst and prolong development spending, even though the company’s existing launch and space-systems businesses continue to expand. Peter Beck’s Neutron Rocket Could Slip to 2027
• Negative Sentiment: Technical and insider-selling concerns add pressure. The stock’s failed breakouts and position below key moving averages have encouraged bearish options strategies. Recent reports also point to significant open-market insider sales without corresponding purchases, which may weigh on investor confidence. Rocket Lab Stock Bear Put Spread

Rocket Lab Company Profile

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source